Skip to main content

Peer Review reports

From: Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes

Original Submission
4 Nov 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
27 Apr 2023 Reviewed Reviewer Report
7 May 2023 Reviewed Reviewer Report - Tomas Milota
22 May 2023 Reviewed Reviewer Report - Kristin Epland
15 Dec 2023 Author responded Author comments - R. Mallick
Resubmission - Version 3
15 Dec 2023 Submitted Manuscript version 3
18 Dec 2023 Author responded Author comments - R. Mallick
Resubmission - Version 4
18 Dec 2023 Submitted Manuscript version 4
19 Dec 2023 Author responded Author comments - R. Mallick
Resubmission - Version 5
19 Dec 2023 Submitted Manuscript version 5
19 Dec 2023 Author responded Author comments - R. Mallick
Resubmission - Version 6
19 Dec 2023 Submitted Manuscript version 6
23 Dec 2023 Reviewed Reviewer Report - Tomas Milota
15 Jan 2024 Reviewed Reviewer Report - Kristin Epland
17 Jan 2024 Reviewed Reviewer Report
29 Jan 2024 Author responded Author comments - R. Mallick
Resubmission - Version 7
29 Jan 2024 Submitted Manuscript version 7
5 Feb 2024 Author responded Author comments - R. Mallick
Resubmission - Version 8
5 Feb 2024 Submitted Manuscript version 8
6 Feb 2024 Author responded Author comments - R. Mallick
Resubmission - Version 9
6 Feb 2024 Submitted Manuscript version 9
Publishing
7 Feb 2024 Editorially accepted
20 Feb 2024 Article published 10.1186/s12865-024-00608-0

You can find further information about peer review here.

Back to article page